Literature DB >> 11472790

Sleep and treatment response in depression: new findings using power spectral analysis.

D J Buysse1, M Hall, A Begley, C R Cherry, P R Houck, S Land, H Ombao, D J Kupfer, E Frank.   

Abstract

This study examined quantitative measures of sleep electroencephalogram (EEG) and phasic rapid eye movements (REM) as correlates of remission and recovery in depressed patients. To address correlates of remission, pre-treatment EEG sleep studies were examined in 130 women outpatients with major depressive disorder treated with interpersonal psychotherapy (IPT). To address correlates of recovery, baseline and post-treatment EEG sleep studies were examined in 23 women who recovered with IPT alone and 23 women who recovered with IPT+fluoxetine. Outcomes included EEG power spectra during non-rapid eye movement (NREM) sleep and REM sleep and quantitative REMs. IPT non-remitters had increased phasic REM compared with remitters, but no significant differences in EEG power spectra. IPT+fluoxetine recoverers, but not IPT recoverers, showed increases in phasic REM and REM percentage from baseline to recovery. In NREM sleep, the IPT+fluoxetine group showed a decrease in alpha power from baseline to recovery, while the IPT group showed a slight increase. The number of REMs was a more robust correlate of remission and recovery than modeled quantitative EEG spectra during NREM or REM sleep. Quantitative REMs may provide a more direct measure of brainstem function and dysfunction during REM sleep than quantitative sleep EEG measures.

Entities:  

Mesh:

Year:  2001        PMID: 11472790     DOI: 10.1016/s0165-1781(01)00270-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

1.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

2.  Disturbed sleep, a novel risk factor for preterm birth?

Authors:  Michele L Okun; James F Luther; Stephen R Wisniewski; Dorothy Sit; Beth A Prairie; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2011-10-03       Impact factor: 2.681

Review 3.  Treatment-resistant depression and mortality after acute coronary syndrome.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

4.  The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects.

Authors:  Elisabeth Friess; Sieglinde Modell; Hans Brunner; Hirokuni Tagaya; Christoph J Lauer; Florian Holsboer; Marcus Ising
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-05-26       Impact factor: 5.270

5.  Comparison of different methods for the evaluation of treatment effects from the sleep EEG of patients with major depression.

Authors:  V Carolina Figueroa Helland; Svetlana Postnova; Udo Schwarz; Jürgen Kurths; Bernd Kundermann; Ulrich Hemmeter; Hans A Braun
Journal:  J Biol Phys       Date:  2008-07-31       Impact factor: 1.365

6.  Sleep-related epilepsy in a Long-Evans hooded rat model of depression.

Authors:  Angela L McDowell; Kingman P Strohl; Pingfu Feng
Journal:  Sleep Breath       Date:  2011-12-29       Impact factor: 2.816

7.  EEG spectral analysis in primary insomnia: NREM period effects and sex differences.

Authors:  Daniel J Buysse; Anne Germain; Martica L Hall; Douglas E Moul; Eric A Nofzinger; Amy Begley; Cindy L Ehlers; Wesley Thompson; David J Kupfer
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

8.  Attachment anxiety, relationship context, and sleep in women with recurrent major depression.

Authors:  Wendy M Troxel; Jill M Cyranowski; Martica Hall; Ellen Frank; Daniel J Buysse
Journal:  Psychosom Med       Date:  2007-08-27       Impact factor: 4.312

9.  Sleep Quality Improvement During Cognitive Behavioral Therapy for Anxiety Disorders.

Authors:  Holly J Ramsawh; Jessica Bomyea; Murray B Stein; Shadha H Cissell; Ariel J Lang
Journal:  Behav Sleep Med       Date:  2015-08-05       Impact factor: 2.964

10.  Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease.

Authors:  Robert M Carney; Kenneth E Freedland; Brian Steinmeyer; Eugene H Rubin; Douglas L Mann; Michael W Rich
Journal:  Psychosom Med       Date:  2016-01       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.